Nisa Investment Advisors LLC Sells 12,894 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Nisa Investment Advisors LLC reduced its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 10.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 114,844 shares of the real estate investment trust’s stock after selling 12,894 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Sabra Health Care REIT were worth $2,137,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of SBRA. Vanguard Group Inc. lifted its stake in shares of Sabra Health Care REIT by 2.5% in the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust’s stock valued at $516,545,000 after purchasing an additional 838,654 shares during the period. Janus Henderson Group PLC lifted its stake in Sabra Health Care REIT by 2.9% in the first quarter. Janus Henderson Group PLC now owns 5,199,682 shares of the real estate investment trust’s stock valued at $76,701,000 after buying an additional 145,548 shares during the period. LSV Asset Management boosted its holdings in Sabra Health Care REIT by 2.5% during the second quarter. LSV Asset Management now owns 4,380,815 shares of the real estate investment trust’s stock worth $67,465,000 after buying an additional 104,800 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Sabra Health Care REIT by 3.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,394,562 shares of the real estate investment trust’s stock worth $52,275,000 after buying an additional 124,825 shares during the period. Finally, APG Asset Management US Inc. increased its stake in shares of Sabra Health Care REIT by 28.9% in the 2nd quarter. APG Asset Management US Inc. now owns 2,562,962 shares of the real estate investment trust’s stock valued at $39,495,000 after acquiring an additional 575,000 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Trading Down 3.9 %

SBRA opened at $18.64 on Friday. The stock has a market capitalization of $4.37 billion, a P/E ratio of 45.46, a P/E/G ratio of 2.77 and a beta of 1.25. The company has a current ratio of 4.27, a quick ratio of 4.27 and a debt-to-equity ratio of 0.89. Sabra Health Care REIT, Inc. has a 12 month low of $12.83 and a 12 month high of $19.78. The firm’s fifty day simple moving average is $18.21 and its 200 day simple moving average is $16.17.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.10 EPS for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). The firm had revenue of $176.14 million during the quarter, compared to the consensus estimate of $166.54 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.50%. The business’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.34 earnings per share. As a group, research analysts anticipate that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.44%. Sabra Health Care REIT’s dividend payout ratio is currently 292.69%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Truist Financial boosted their price objective on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $16.00 to $20.00 in a report on Tuesday, October 1st. Scotiabank raised their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research note on Friday, October 11th. Finally, Citigroup upgraded Sabra Health Care REIT from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $17.00 to $20.00 in a report on Friday, September 13th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $18.38.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.